1 85800sek
1,1 %
Date:2026-03-04Time:12:19:37Latest report:Q4-2025List:Large CapTicker:AZN
Market Cap:2 879 370 msekEnterprise Value:3 095 038 msekNet Sales:58 739 musdEarnings:10 225 musdEmployees:0ISIN:GB0009895292

Ratios

10-year key figure history for AstraZeneca turnover, profit, dividend, equity, PE and PB.

Pre
Pre

Stockprice

Price movement for AstraZeneca with index and moving average MA50 and MA200.

Stockprice:1 857,00
MA50:1 750,91
MA200:1 565,10
Price/MA200:18,7 %
RSI (14):59,7
Price/MA50:6,1 %

Description

AstraZeneca is a global pharmaceutical company focused on the research, development and marketing of prescription medicines, primarily for the treatment of diseases in the therapeutic areas of respiratory, cardiovascular/metabolic and cancer. In addition to its core business, the company also has a focus on the areas of autoimmunity, neuroscience and infection. AstraZeneca operates in all global regions and is headquartered in Cambridge, UK.

Pharmaceuticals